MSB 8.42% $1.03 mesoblast limited

Ann: EAP for Remestemcel-L in Children with MIS-C due to COVID-19, page-106

  1. 1,252 Posts.
    lightbulb Created with Sketch. 1400
    "Folks, this is much more than Remestemcel-L for COVID-19 induced ARDS"

    Truer words never said @The Yankee. It is so much more that imagination can't encompass it.

    Just 100 days ago MSB holders were extremely pleased. We had one phase 3 breasting the wire and two others smartly out of the blocks and no one between them and the finish line. Happy days.

    Then a unicorn appeared. Totally unexpected but very welcome.

    But who believes in unicorns? Need to examine it very closely before believing it exists. A RCT should find out.

    But wait, the unicorn has had a foal. And The Yankee sees it's a filly. Breeding stock!

    The stud book is being rewritten almost daily.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.03
Change
0.080(8.42%)
Mkt cap ! $1.176B
Open High Low Value Volume
95.5¢ $1.03 95.0¢ $43.38M 42.28M

Buyers (Bids)

No. Vol. Price($)
4 72752 $1.01
 

Sellers (Offers)

Price($) Vol. No.
$1.03 205100 2
View Market Depth
Last trade - 16.10pm 30/08/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.